NYSE:EW
Edwards Lifesciences Corporation Stock News
$85.95
-0.480 (-0.555%)
At Close: Apr 29, 2024
Edwards Lifesciences Stock Slumps on Guidance Cut
10:58am, Friday, 28'th Oct 2022
Edwards Lifesciences says quarterly sales for its transcatheter aortic valve replacement rose 1% but were impacted by, among other things, 'persistent U.S. hospital staffing shortages.'
Edwards Lifesciences Corp (EW) Q3 2022 Earnings Call Transcript
09:45pm, Thursday, 27'th Oct 2022
Edwards Lifesciences Corp (NYSE:EW ) Q3 2022 Earnings Conference Call October 27, 2022 5:00 PM ET Company Participants Mark Wilterding - VP, IR Michael Mussallem - Chairman & CEO Scott Ullem - Corpora
Edwards Slashes 2022 Profit Outlook, Citing Hospital, Dollar Challenges
04:30pm, Thursday, 27'th Oct 2022
Edwards Lifesciences slashed its 2022 profit outlook on Thursday, noting hospital and dollar challenges. But EW stock remained muted.
EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022
07:05am, Thursday, 20'th Oct 2022
IRVINE, Calif. , Oct. 20, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2022 after the market closes on Thursday, Oc
What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?
01:33pm, Tuesday, 18'th Oct 2022
Within the TAVR arm, Edwards Lifesciences (EW) is likely to have witnessed continued growth in procedures across the United States and worldwide.
Edwards Lifesciences (EW) TAVR Sales Strong Amid Macro Issues
03:03pm, Friday, 07'th Oct 2022
Edwards Lifesciences (EW) expects full-year 2022 underlying sales growth in the mid-single-digit range on the back of strength in demand for products used in more intense surgeries.
These Are the Top 10 Holdings of David Rolfe
08:02pm, Tuesday, 04'th Oct 2022
David A. Rolfe is the chief investment officer at Wedgewood Partners and has been managing Wedgewood's portfolio for 18 years.
Stocks To Watch: Big Events For Tesla, Amazon And Intel
01:08am, Saturday, 24'th Sep 2022 Seeking Alpha
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
What 8 Analyst Ratings Have To Say About Edwards Lifesciences
01:18pm, Thursday, 22'nd Sep 2022 Benzinga
Within the last quarter, Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
3
1
0
0
Las
HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco
12:20pm, Thursday, 22'nd Sep 2022 Benzinga
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61
Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve
03:26pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve
12:47pm, Tuesday, 13'th Sep 2022
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
Edward Lifesciences (EW) Gains From New Products Amid Cost Woe
03:58pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
Edward Lifesciences (EW) Gains From New Products Amid Cost Woe
01:33pm, Wednesday, 07'th Sep 2022
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
OCPNY or EW: Which Is the Better Value Stock Right Now?
03:40pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
OCPNY vs. EW: Which Stock Is the Better Value Option?
